➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
McKesson
Dow
Moodys
Express Scripts

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Litigation Details for Pfizer Inc. v. Zydus Pharmaceuticals USA Inc. (D. Del. 2012)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Pfizer Inc. v. Zydus Pharmaceuticals USA Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Pfizer Inc. v. Zydus Pharmaceuticals USA Inc. (D. Del. 2012)

Date Filed Document No. Description Snippet Link To Document
2013-12-02 257 1. Background. The patent in suit, U.S. Patent No. 6,673,838 (“the ‘838 patent”), issued January 6, …permeability, and bloavailability.” (‘838 patent, co|. 1:51-56) The ‘838 patent is listed in the Orange Book for…the generic drug manufacturer must certify that a patent “is invalid or will not be infringed by the manufacture…sale of the" generic drug; the holder of the patent has 45 days in which to file suit to resolve the…may not approve the ANDA until expiration of the patent, resolution of the lawsuit, or 30 months after External link to document
2012-11-07 26 of United States Patent No. 6,673,838 (“the ‘838 patent”) and United States Patent No. 8,269,040 (“the…certification COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 6,673,838 19. Plaintiffs reallege and incorporate…declaring that Alembic has infringed U.S. Patent No. 6,673,838; Case 1:12-cv-OO808-SLR Document 26 Filed…ACTION 1. This is an action for patent infringement under the patent laws of the States, Title 35 of …and 1400(b). THE PATENTs-IN-sUIT 11. On January 6, 2004, the United States Patent and Trademark Office External link to document
2012-11-07 27 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,269,040 B2; . (Blumenfeld, …2012 6 August 2014 1:12-cv-00808 830 Patent None District Court, D. Delaware External link to document
2014-03-17 305 Invalidity of Claims 4-18 of U.S. Patent No. 6,673,838 and Claims 1-2 of U.S. Patent No. 8,269,040 filed by Alembic…2012 6 August 2014 1:12-cv-00808 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Johnson and Johnson
McKesson
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.